期刊文献+

静脉注射碘佛醇致过敏性休克死亡 被引量:6

Death from anaphylactic shock caused by intravenous injection of ioversol
原文传递
导出
摘要 1例38岁女性患者因左下肢血管畸形行左下肢顺行性深静脉造影,在静脉注射地塞米松10 mg后,以0.3 ml/s的速度静脉注射0.9%氯化钠注射液50 ml+碘佛醇注射液50 ml。注射完毕后约1 min,患者出现面色苍白、口唇发绀、胸闷、恶心、呕吐,血压测不到,无自主呼吸。心电监护显示心室颤动。即刻静脉注射地塞米松、肾上腺素,并数次静脉滴注多巴胺、异丙肾上腺素、胺碘酮、碳酸氢钠、阿托品等,给予胸外心脏按压及口对口人工呼吸、电除颤并置入临时起搏器。2 d后患者终因心室扑动抢救无效死亡。 A 38-year-old woman with left lower extremity vascular malformations received anterograde venography of deep vein of left lower limb. She was given an IV bolus of dexamethasone 10 rag, and followed by 0.9% sodium chloride injection 50 ml plus ioversol injection 50 ml at the rate of 0.3 ml per second. About 1 minute after IV bolus , the patient appeared pale, had cyanotic lips, chest stuffy, nausea, vomiting, blood pressure undeteetable and no autonomous respiration. ECG showed ventricular fibrillation. She was given an IV bolus of dexamethasone and epinephrine immediately, and IV infusion of dopamine, isoprenaline, amiodarone, sodium bicarbonate, and atropine for several times. At the same time she was given closed cardiac massage, mouth-to-mouth resuscitation and electric defibrillation, and a temporary pacemaker was implanted. Two days later, the patient finally died despite resuscitation attempts of ventricular flutter.
出处 《药物不良反应杂志》 CSCD 2013年第2期95-96,共2页 Adverse Drug Reactions Journal
关键词 碘佛醇 休克 Ioversol Shock
  • 相关文献

参考文献4

二级参考文献35

  • 1李彪,齐海梅,裕东洁,姚稚明,汤天清,赵洪山,褚德发,吴华.Cockcroft-Gault公式和简化MDRD公式估算老年人肾功能准确性的比较研究[J].中华老年医学杂志,2007,26(2):97-100. 被引量:19
  • 2Yamaguchi K, Katayama H, Takashima T, et al. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1991, 178:363-367.
  • 3Widmark JM. Imaging-related medications: a class overview. Proc (Bayl Univ Med Cent), 2007, 20:408-417.
  • 4Thomsen HS, Morcos SK. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Badiol, 2006,16:1835-1840.
  • 5Al Ghonaim M, Pannu N. Prevention and treatment of contrastinduced nephropathy. Tech Vase lnterv Radiol, 2006, 9:42-49.
  • 6McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006, 98 :SK-13K.
  • 7McCuUough P. Outcomes of contrast-induced nephropathy: experience in patientsundergoing cardiovascular intervention. Catheter Cardiovasc lnterv, 2006, 67:335-343.
  • 8Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrastinduced nephropathy..lAMA, 2006, 295:2765-2779.
  • 9Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation, 2006, 113: 1799 -1806.
  • 10Person PB, Tepel M. Contrast medium-induced nephropathy: the pathophysiology. Kidney Int Suppl, 2006 :S8-S10.

共引文献81

同被引文献73

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部